Table 1 Antimalarial treatment outcomes for the 4ABC Trial [19]
| Treatment | Cured | Missing outcome (indeterminate recurrence) | Recrudescence | New Infection | Total |
|---|---|---|---|---|---|
| AL | 847 (73.0%) † | 29 (2.5%) | 41 (3.5%) | 243 (21.0%) | 1,160 |
| ASAQ | 744 (81.8%) | 20 (2.2%) | 18 (2.0%) | 127 (14.0%) | 909 |
| DP | 1,242 (91.2%) | 13 (1.0%) | 22 (1.6%) | 85 (6.2%) | 1,362 |